CD8A and cancer: The authors demonstrated bEV accumulation in subcutaneous mouse tumor models and the capacity to elicit a durable anti-cancer immune response that leads to substantial reductions in tumor sizes, dependent on CD8+ cells and the presence of IFN-γ [40].